SEIKAGAKU CORPORATION
4548 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 千代田区丸の内一丁目６番１号
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
SEIKAGAKU CORPORATION is a leading Japanese biotechnology company specializing in the research, development, manufacturing, and marketing of pharmaceuticals and medical devices. Founded in 1947, Seikagaku is renowned for its expertise in glycoscience, focusing on innovative treatments that harness the therapeutic potential of glycosaminoglycans. The company is dedicated to improving patient outcomes through advanced biopharmaceuticals, particularly in the fields of osteoarthritis and other musculoskeletal disorders. With a strong commitment to research and development, Seikagaku aims to address unmet medical needs and expand its global presence, contributing to the advancement of healthcare solutions worldwide.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-24 08:14 |
Inside Information Statement
臨時報告書
|
Japanese | 23.0 KB | |
| 2025-06-23 06:58 |
Internal Control over Financial Reporting
内部統制報告書－第79期(2024/04/01－2025/03/31)
|
Japanese | 22.6 KB | |
| 2025-06-23 06:57 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
| 2025-06-23 06:56 |
Annual Report
有価証券報告書－第79期(2024/04/01－2025/03/31)
|
Japanese | 1.1 MB | |
| 2024-11-12 06:58 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
| 2024-11-12 06:56 |
Interim Report
半期報告書－第79期(2024/04/01－2025/03/31)
|
Japanese | 191.1 KB | |
| 2024-06-27 06:53 |
Internal Control over Financial Reporting
内部統制報告書－第78期(2023/04/01－2024/03/31)
|
Japanese | 21.9 KB | |
| 2024-06-27 06:52 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
| 2024-06-27 06:51 |
Annual Report
有価証券報告書－第78期(2023/04/01－2024/03/31)
|
Japanese | 1.1 MB | |
| 2024-06-25 04:10 |
Inside Information Statement
臨時報告書
|
Japanese | 23.7 KB | |
| 2024-02-14 08:57 |
Quarterly Report
四半期報告書－第78期第3四半期(2023/10/01－2023/12/31)
|
Japanese | 165.1 KB | |
| 2024-02-14 08:57 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
| 2023-11-14 05:06 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
| 2023-11-14 05:05 |
Quarterly Report
四半期報告書－第78期第2四半期(2023/07/01－2023/09/30)
|
Japanese | 195.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |